BBVA
MRNA icon

Banco Bilbao Vizcaya Argentaria’s Moderna MRNA Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.8M Sell
39,437
-42,175
-52% -$2.18M 0.02% 381
2026
Q1 		$3.96M Buy
81,612
+13,071
+19% +$610K 0.03% 323
2025
Q4 		$2.03M Sell
68,541
-5,142
-7% -$140K 0.01% 430
2025
Q3 		$1.84M Sell
73,683
-84,447
-53% -$2.36M 0.01% 435
2025
Q2 		$4.4M Buy
158,130
+4,208
+3% +$111K 0.04% 280
2025
Q1 		$4.38M Sell
153,922
-183,308
-54% -$6.5M 0.04% 275
2024
Q4 		$13.7M Buy
337,230
+167,902
+99% +$8.02M 0.14% 134
2024
Q3 		$11.2M Buy
169,328
+34,472
+26% +$3.16M 0.11% 170
2024
Q2 		$16.1M Sell
134,856
-18,900
-12% -$2.39M 0.17% 115
2024
Q1 		$16.4M Sell
153,756
-136,704
-47% -$13.8M 0.19% 112
2023
Q4 		$17M Buy
290,460
+209,074
+257% +$17.6M 0.2% 114
2023
Q3 		$8.33M Sell
81,386
-18,194
-18% -$2.03M 0.11% 190
2023
Q2 		$12.2M Buy
99,580
+3,219
+3% +$429K 0.16% 150
2023
Q1 		$14.7M Buy
96,361
+7,581
+9% +$1.25M 0.18% 117
2022
Q4 		$15.7M Buy
88,780
+67,227
+312% +$11M 0.23% 101
2022
Q3 		$2.57M Sell
21,553
-55,166
-72% -$8.37M 0.04% 319
2022
Q2 		$11M Sell
76,719
-3,602
-4% -$515K 0.17% 126
2022
Q1 		$14M Buy
80,321
+12,954
+19% +$2.18M 0.19% 110
2021
Q4 		$17.1M Buy
67,367
+30,266
+82% +$8.85M 0.23% 89
2021
Q3 		$14.3M Buy
37,101
+18,237
+97% +$6.73M 0.22% 82
2021
Q2 		$4.44M Sell
18,864
-19,256
-51% -$3.44M 0.08% 224
2021
Q1 		$4.83M Buy
38,120
+36,023
+1,718% +$5.22M 0.1% 198
2020
Q4 		$219K Sell
2,097
-11,423
-84% -$1.16M 0.01% 678
2020
Q3 		$956K Buy
+13,520
New +$943K 0.03% 422

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's MRNA Position: Q2 2026 in Review

Banco Bilbao Vizcaya Argentaria reduced its Moderna (MRNA) stake by 52% in Q2 2026, selling an estimated $2.18M and leaving 39,437 shares worth $2.8M. The position accounts for 0.02% of the portfolio, ranked #381.

Banco Bilbao Vizcaya Argentaria first reported a position in MRNA in Q3 2020 and has held it in 24 quarters since. The position peaked at $17.1M in Q4 2021. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Banco Bilbao Vizcaya Argentaria held 39,437 shares of Moderna worth $2.8M as of Q2 2026.
  • Banco Bilbao Vizcaya Argentaria sold 42,175 Moderna shares in Q2 2026, an estimated $2.18M.
  • Moderna made up 0.02% of Banco Bilbao Vizcaya Argentaria's portfolio in Q2 2026, its #381 holding.
  • Banco Bilbao Vizcaya Argentaria first reported a position in Moderna in Q3 2020 and has held it in 24 quarters since.
  • Banco Bilbao Vizcaya Argentaria's Moderna position peaked at $17.1M in Q4 2021.
  • 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q2 2026, filed 12 Aug 2026.